Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Maral YerdenovaDepartment of Epidemiology with the Course of HIV Infection and IK, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.ORCID 0000-0002-4375-9506
Aigulsum IzekenovaDepartment of Epidemiology with the Course of HIV Infection and IK, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.ORCID 0000-0003-3850-8689
Akbope MyrkassymovaDepartment of Biostatistics and Basics of Scientific Research, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.
Gaukhar MergenovaDepartment of Epidemiology with the Course of HIV Infection and IK, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.
Mohammed MerzahDepartment of Public Health and Epidemiology, Faculty of General Medicine, University of Debrecen, 4028 Debrecen, Hungary.
Balday IssenovaDepartment of Nursing, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.
Maksat MamyrkulDepartment of Health Politics and Management, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.ORCID 0000-0001-8091-0255
Aliya AtabayevaDepartment of Public Health, NJSC Semey Medical University, Semey 071400, Kazakhstan.ORCID 0000-0001-7725-2255
Vytenis KalibatasDepartment of Health Management, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.ORCID 0000-0002-5923-8166
Dejan NikolicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-0609-9916
Yineng ChenCollege of Integrated Health Science, University at Albany, Albany, NY 12144, USA.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
access to healthcareCOVID-19healthcare deliveryhealthcare serviceshemato-oncology carepandemics
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Impact of the COVID-19 Pandemic on Hemato-Oncology Services: A Retrospective Dual-Center Cohort Study in Kazakhstan. · full record | OpenQuestion